United States · Series B startup

Who invested in Lumense

2 rounds we have observed, with the 3 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechIoT

Funding summaryUpdated 26 Oct 2026

$3.6Mraised across 2 rounds since 2012, from 2 sources

$1.0MSeed$2.6MSeries B
Latest round
Series B, $2.6MNov 2013
Step-upi
2.6×
Investors
3
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2013
$1.0MSeed$2.6MSeries B
First round
Seed, $1.0M
May 2012
Biggest round
$2.6M
Series B · Nov 2013
Between rounds
18 months
from the last two

The rounds

  1. Nov 2013
  2. May 2012
    Seed$1.0M

    No investor was named in the report.

    From a historical funding record

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Everyone who backed them

The Coca-Cola CompanyCorporate VC1round
CoreCard CorporationGrowth equity1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Lumense

Who invested in Lumense?

Lumense's investors include GRA Venture Fund, LLC, The Coca-Cola Company and CoreCard Corporation.

How much has Lumense raised?

Lumense has raised $3.6M across 2 rounds since 2012.

When did Lumense last raise?

Lumense's most recent round was a Series B of $2.6M in Nov 2013.

What was Lumense's biggest round?

Its most recent round, $2.6M in Nov 2013, is also its largest on record.

Who backed Lumense first?

Lumense's first round on record, in Nov 2013, was backed by GRA Venture Fund, LLC, The Coca-Cola Company and CoreCard Corporation.

What stage is Lumense at?

Lumense's latest named round is a Series B, in Nov 2013.

Where is Lumense based?

Lumense is based in the United States.

Companies like Lumense

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.